Elucidating Rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers.

被引：0
|
作者：
Zheng, H. [1 ]
Huang, Y. [1 ]
Frassetto, L. [1 ]
Benet, L. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 49 条
  • [31] Effects of single intravenous (IV) doses of recombinant human interleukin-10 (rhIL-10) on subsets of blood leukocytes in healthy volunteers.
    Huhn, RD
    Pennline, K
    Sabo, R
    Clarke, L
    Affrime, MB
    Cutler, DL
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A275 - A275
  • [32] A study to investigate the tolerability, pharmacokinetics and effects on blood pressure, heart rate and substance p-induced wheal and flare response of single, oral doses of 4991W93 in healthy volunteers.
    McColm, JA
    Peck, RW
    Koch, KM
    Julious, S
    Collyer, SM
    Hulbert, R
    CEPHALALGIA, 1999, 19 (04) : 406 - 406
  • [33] Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions
    Strand, Maren Cecilie
    Ramaekers, Johannes G.
    Gjerde, Hallvard
    Morland, Jorg
    Vindenes, Vigdis
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (05) : 489 - 493
  • [34] Pharmacodynamics and pharmacokinetics of dose ranging effects of oralin versus s.c. regular insulin in healthy volunteers
    Raz, I
    Cernea, S
    Wohlgelernter, J
    Modi, P
    Kidron, M
    DIABETES, 2004, 53 : A4 - A4
  • [35] Pharmacodynamics and pharmacokinetics of dose ranging effects of Oralin versus s.c. regular insulin in healthy volunteers
    Cernea, S
    Wohlgelernter, J
    Kidron, M
    Modi, P
    Raz, I
    DIABETOLOGIA, 2004, 47 : A5 - A5
  • [36] Pharmacokinetics of the new human hepatitis B immunoglobulin BT088 after subcutaneous (s.c.) and intramuscular (i.m.) application in healthy volunteers.
    Szymanski, J
    Haffner, S
    Sonnenburg, C
    Thürmann, PA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 720 - 721
  • [37] Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocournon in healthy volunteers
    Kirchheiner, J
    Ufer, M
    Walter, EC
    Kammerer, B
    Kahlich, R
    Meisel, C
    Schwab, M
    Gleiter, CH
    Rane, A
    Roots, I
    Brockmöller, J
    PHARMACOGENETICS, 2004, 14 (01): : 19 - 26
  • [38] Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity
    J. Persson
    J. Hasselström
    A. Maurset
    I. Öye
    J.-O. Svensson
    O. Almqvist
    H. Scheinin
    L. Gustafsson
    O. Almqvist
    European Journal of Clinical Pharmacology, 2002, 57 : 869 - 875
  • [39] Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity
    Persson, J
    Hasselström, J
    Maurset, A
    Öye, I
    Svensson, JO
    Almqvist, O
    Scheinin, H
    Gustafsson, LL
    Almqvist, O
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 57 (12) : 869 - 875
  • [40] Cumulative systemic pharmacodynamic effects after application of budesonide pH-modified-release-capsules and tablets in patients with Crohn's disease as compared to healthy volunteers.
    Tromm, A
    Mollmann, HW
    Weisser, H
    Wagner, M
    vonHeymann, S
    May, B
    Krieg, M
    Hochhaus, G
    Derendorf, H
    GASTROENTEROLOGY, 1996, 110 (04) : A1031 - A1031
12345